Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah A Bradley

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Journal (Sudbury, Mass.)|February 28, 2008
Promising novel cytotoxic agents and combinations in metastatic prostate cancerDeborah A Bradley, Maha Hussain
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|August 29, 2006
Diagnosis and management of spinal cord sarcoidosisDeborah A Bradley, Elyse E Lower, Robert P Baughman
The Journal of Urology|July 24, 2007
Bone directed therapies for prostate cancerDeborah A Bradley, Maha Hussain, Robert S Dipaola, et al.
Breast Cancer Research and Treatment|March 17, 2005
Impact of metastatic estrogen receptor and progesterone receptor status on survivalElyse E Lower, Eleanor L Glass, Deborah A Bradley, et al.
Chest|August 16, 2005
Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trialRobert P Baughman, Elyse E Lower, Deborah A Bradley, et al.
CA: a Cancer Journal for Clinicians|July 13, 2007
The lethal phenotype of cancer: the molecular basis of death due to malignancyRobert D Loberg, Deborah A Bradley, Scott A Tomlins, et al.
Clinical Genitourinary Cancer|February 15, 2008
Randomized, double-blind, placebo-controlled phase II trial of maintenance sunitinib versus placebo after chemotherapy for patients with advanced urothelial carcinoma: scientific rationale and study designDeborah A Bradley, Rodney Dunn, David Nanus, et al.
Expert Review of Vaccines|June 23, 2011
CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancerMichael A Morse, Deborah A Bradley, Tibor Keler, et al.
Neoplasia (New York, N.Y.)|December 18, 2007
A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the boneKuei C Lee, Deborah A Bradley, Maha Hussain, et al.
Investigational New Drugs|March 26, 2010
Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortiumDeborah A Bradley, Stephanie Daignault, Charles J Ryan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Journal (Sudbury, Mass.)|February 28, 2008
Promising novel cytotoxic agents and combinations in metastatic prostate cancerDeborah A Bradley, Maha Hussain
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|August 29, 2006
Diagnosis and management of spinal cord sarcoidosisDeborah A Bradley, Elyse E Lower, Robert P Baughman
The Journal of Urology|July 24, 2007
Bone directed therapies for prostate cancerDeborah A Bradley, Maha Hussain, Robert S Dipaola, et al.
Breast Cancer Research and Treatment|March 17, 2005
Impact of metastatic estrogen receptor and progesterone receptor status on survivalElyse E Lower, Eleanor L Glass, Deborah A Bradley, et al.
Chest|August 16, 2005
Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trialRobert P Baughman, Elyse E Lower, Deborah A Bradley, et al.
CA: a Cancer Journal for Clinicians|July 13, 2007
The lethal phenotype of cancer: the molecular basis of death due to malignancyRobert D Loberg, Deborah A Bradley, Scott A Tomlins, et al.
Clinical Genitourinary Cancer|February 15, 2008
Randomized, double-blind, placebo-controlled phase II trial of maintenance sunitinib versus placebo after chemotherapy for patients with advanced urothelial carcinoma: scientific rationale and study designDeborah A Bradley, Rodney Dunn, David Nanus, et al.
Expert Review of Vaccines|June 23, 2011
CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancerMichael A Morse, Deborah A Bradley, Tibor Keler, et al.
Neoplasia (New York, N.Y.)|December 18, 2007
A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the boneKuei C Lee, Deborah A Bradley, Maha Hussain, et al.
Investigational New Drugs|March 26, 2010
Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortiumDeborah A Bradley, Stephanie Daignault, Charles J Ryan, et al.
Pageof 1